Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
432M
-
Number of holders
-
451
-
Total 13F shares, excl. options
-
342M
-
Shares change
-
+25.5M
-
Total reported value, excl. options
-
$12.3B
-
Value change
-
+$948M
-
Put/Call ratio
-
0.2
-
Number of buys
-
248
-
Number of sells
-
-215
-
Price
-
$36.03
Significant Holders of Royalty Pharma plc - Common Stock (RPRX) as of Q2 2025
534 filings reported holding RPRX - Royalty Pharma plc - Common Stock as of Q2 2025.
Royalty Pharma plc - Common Stock (RPRX) has 451 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 342M shares
of 432M outstanding shares and own 79.13% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (46.6M shares), FMR LLC (40.4M shares), VANGUARD GROUP INC (36.4M shares), BlackRock, Inc. (25.4M shares), Capital International Investors (21.9M shares), BAILLIE GIFFORD & CO (18M shares), Swedbank AB (12.2M shares), STATE STREET CORP (10.2M shares), GEODE CAPITAL MANAGEMENT, LLC (8.18M shares), and Caledonia (Private) Investments Pty Ltd (6.44M shares).
This table shows the top 451 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.